Abstract
Ovarian cancer causes more deaths than any other cancer of the female reproductive system and accounts for 4% of all female cancers. In 2010, an estimated 1 in 71 women in the United States will develop ovarian cancer in their lifetime with an estimated 13,850 deaths (Cancer Facts and Figures 2010). However, death rates for ovarian cancer have been decreasing by 1.4% per year since 2002 which is partly due to accurate staging of ovarian carcinoma which is vital for the appropriate management and counseling of patients. Identifying the volume and locations of tumor is valuable in planning percutaneous tissue biopsy and triaging patients to either primary cytoreductive surgery, or primary platinum-based chemotherapy. This chapter will discuss the classification, risk factors, current imaging modalities, and staging of ovarian cancer to provide a comprehensive overview for the clinical radiologist.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Benedet JL, Bender H, Jones III H, et al. FIGO staging and clinical practical guidelines in the management of gynaecological cancers. FIGO Committee on gynaecologic oncology. Int J Gynaecol Obstet. 2000;70:209–62.
Buy JN, Moss AA, Ghossain MA, et al. Peritoneal implants from ovarian tumors: CT findings. Radiology. 1988;169:691–4.
Cancer Facts and Figures. Atlanta: American Cancer Society; 2010. http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf
Chan JK, Urban R, Hu JM, Shin JY, Hussain A, Teng NN, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. BJ Cancer. 2007;96:1817–22.
Forstner R, Sala E, Kinkel K, Spencer JA. European Society of urogenital radiology. ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol. 2010;20:2773–80.
Fujii S, Matsusue E, Kanasaki Y, et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 2008;18:18–23.
Griffin N, Grant L, Freeman SJ, et al. Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique? Eur Radiol. 2009;19:230–5.
Gu P, Pan LL, Wu SQ, Sun L, Huang G. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2009;71:164–74.
Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol. 2000;19:3–10.
Levy AD, Shaw JC, Sobin LH. Secondary tumors and tumor like lesions of the peritoneal cavity: imaging features with pathologic correlation. Radiographics. 2009;29:347–73.
Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am. 2003;12:585–603.
Sobin L, Gospodarowicz M, Wittekind C, editors. TNM classification of malignant tumours, Ovary (ICD-O C56). 7th ed. Chichester/Hoboken: Wiley-Blackwell; 2009.
Travassoli FA, Devilee T, editors. Pathology and genetics. Tumours of the breast and female genital organs. WHO classification of tumour. Geneva: WHO; 2003.
Woodward PJ, Hosseinzadeh K, Saenger JS. Radiologic staging of ovarian carcinoma with pathologic correlation. From the archives of the AFIP. Radiographics. 2004;24:225–46.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Moyle, P., Sala, E. (2013). Malignant Neoplasms, Staging of Ovarian Cancer. In: Hamm, B., Ros, P.R. (eds) Abdominal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13327-5_140
Download citation
DOI: https://doi.org/10.1007/978-3-642-13327-5_140
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-13326-8
Online ISBN: 978-3-642-13327-5
eBook Packages: MedicineReference Module Medicine